SCHEMBL6297971

SCHEMBL6297971

Cc1c(C)c(C=C(c2ccccc2)c2ccc(Br)cc2)c2ccccc2c1C=C(c1ccccc1)c1ccc(Br)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.40
ESR1 P03372 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP2C19 P33261 3/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP2C9 P11712 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B2 P19099 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CYP3A4 P08684 2/20 0.36
NFKB1 P19838 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6297970 1.00 PTGS2 (0.40) PTGS2ESR1CYP1A2CYP2C19ALDH1A1
SCHEMBL6304314 0.90 ESR1 (0.41) PTGS2ESR1ALDH1A1CYP19A1CYP11B2
SCHEMBL6304315 0.90 ESR1 (0.41) PTGS2ESR1ALDH1A1CYP19A1CYP11B2
SCHEMBL4599993 0.78 CYP19A1 (0.48) PTGS2ESR1CYP1A2CYP2C19ALDH1A1
SCHEMBL6300151 0.75 CYP3A4 (0.38) PTGS2ESR1CYP1A2CYP2C19ALDH1A1
SCHEMBL6297766 0.75 C1S (0.42) PTGS2ALDH1A1CYP19A1CYP11B2NFKB1
SCHEMBL6297768 0.75 C1S (0.42) PTGS2ALDH1A1CYP19A1CYP11B2NFKB1
SCHEMBL6300153 0.75 CYP3A4 (0.38) PTGS2ESR1CYP1A2CYP2C19ALDH1A1
SCHEMBL6517636 0.74 ESR1 (0.59) PTGS2ESR1ALDH1A1CYP19A1CYP11B2
SCHEMBL987335 0.74 ESR1 (0.64) PTGS2ESR1NPSR1CYP19A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6875895-B2 Such as 1,4-bis(2-(4-bromophenyl)-2-phenylethenyl)-2-(2-ethylhexyloxy)-5 -methoxybenzene; for polymerization into a light-emitting material SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-05 US disclosed
US-20030100786-A1 Bis (diphenylvinyl) arene compound SUMITOMO CHEMICAL COMPANY, LIMITED 2003-05-29 US disclosed
EP-1288184-A1 Bis(diphenylvinyl)arene compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100786-A1 Bis (diphenylvinyl) arene compound CBR1, AR, CYP1B1 PTGS2 1590/4885ESR1 343/4885CYP1A2 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.